MICHELE MACK: Open Payments
NPI 1609806272 · NORTH HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 34 payments from 19 companies in 2025. Trend: 2023 $964 · 2024 $855 · 2025 $2,068
Food & beverage: $2,068
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $310 |
| Genentech, Inc. | 2 | $289 |
| Amgen Inc. | 2 | $275 |
| Biogen, Inc. | 1 | $146 |
| PFIZER INC. | 2 | $146 |
| E.R. Squibb & Sons, L.L.C. | 1 | $132 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Sage Therapeutics, LLC | 4 | $93 |
Products named: ZURZUVAE, ANNOVERA, REPATHA, Xolair, COBENFY, VOQUEZNA, VYVGART, BRAFTOVI.
Industry payments across CA — which companies pay providers there.
